Slashdot Mirror
China Negotiating For Cheaper Cancer Drugs (reuters.com)
hackingbear writes: "China's medical insurance regulator will begin negotiations with domestic and overseas pharmaceutical companies to lower prices of cancer drugs in a bid to cut the financial burden on patients," reports Reuters. "The State Medical Insurance Administration said it was preparing to include more cancer drugs on its list of medicines eligible for reimbursement, and said 10 foreign and eight domestic pharmaceutical companies had expressed a willingness to work with the authority."
Unlike India, or what we may have been told, China enforces pharmaceutical patents rigorously. Recently, the Chinese box office hit Dying to Survive, which told the real life story of a leukemia patient/businessman put on trial due to smuggling imitation drugs to help fellow patients who cannot pay the exorbitant cost of a drug produced by a Swiss pharmaceutical giant, has brought in huge revenues and rave reviews since the movie was released on July 5. Last year, China forced two rounds of NRDL negotiations after seven years of stasis. More than a dozen cancer drugs, including AstraZeneca's Iressa and Roche's Herceptin, are now covered by the country's insurance program, but only after the companies agreed to huge discounts -- a typical move trading lower prices for higher volume. Demand for Herceptin, for example, surged after the discount and triggered a national shortage.
Unlike India, or what we may have been told, China enforces pharmaceutical patents rigorously. Recently, the Chinese box office hit Dying to Survive, which told the real life story of a leukemia patient/businessman put on trial due to smuggling imitation drugs to help fellow patients who cannot pay the exorbitant cost of a drug produced by a Swiss pharmaceutical giant, has brought in huge revenues and rave reviews since the movie was released on July 5. Last year, China forced two rounds of NRDL negotiations after seven years of stasis. More than a dozen cancer drugs, including AstraZeneca's Iressa and Roche's Herceptin, are now covered by the country's insurance program, but only after the companies agreed to huge discounts -- a typical move trading lower prices for higher volume. Demand for Herceptin, for example, surged after the discount and triggered a national shortage.
I understand that finding, testing and indeed certifying new drugs is costly. I have worked in the certification world for 15 years.
I also understand that a company needs to make a profit.
Having said that, a drug company is not the same as a company like Apple or Samsung or Volkswagen.
You can live without your iphone, so if you cannot afford the 1k price of an iphone..well...don't buy it.
Can you do the same with that Hep-C cure? With AIDS drugs? No, you need them to survive. You will literally die if you do not get them. So, as we have seen many, many times over the years, old drug patents are purchased by third parties and the price is increased by, often times, more than 1000%.
Or a super computer has slightly varied and already existing drug and a slight improvement is seen for MS patients. So, these are sold for $3000 per treatment.
This is literally holding the public hostage.
Sure, the assholes may argue... you can choose not to take it. Let us see your opinion when your little girls gets cancer (god forbid it) and you choose not to pay the 25000$ treatment because it's not fully covered by the insurance.
In my opinion, it is fucking disgusting that this is allowed to happen. Utterly fucking disgusting. I would argue that anyone who thinks it is reasonable that drug companies should be able to charge whatever they like for literally life saving drugs, then you sir, are a complete and total sack of shit and the reason why we cannot have nice things. So, go fuck yourself.
One of the advantages of a single payer system is bulk discounts. Congratulations to China!
Same in the UK. This is how national health services are supposed to work. Leave it to corporations and consumer choice? You get the USA's hyper-exploitative system where patients are stuffed full of questionable drugs, many of which they probably don't even need.
That is a blatant lie.
Look at their numbers. Nearly all is marketing, lobbyism and sales.
Pretty much all drugs come from them taking some thing they found in nature (e.g. my blood medication, wich is one of the most popular in the world, literally came from a snake poison suggested by a shaman),
and then cluelessly tinkering with it, to see what the modified variants will do.
A researcher for a big pharma company admitted that they really have no idea what they are doing, in an AMA in Reddit, a few years ago. (And when they fail, you get stuff like meth and krokodil popping up on the black market. Or it gets sold under its biggest side-effect.)
Mind you, I'm fine with them doing that. It's useful.
What I am not fine with, is them claiming it is soo hard, and soo valuable.
Let alone it having to be for-profit (aka taking more money than they actuall worked for in return) or private.
Let us, together (aka an actual government, not the US corporate oligarchy sock puppet scapegoat), give out great research grants, based on acrual potential usefulness for society! And when it results in something, allow everyone to manufacture it.
Because the researchera were already paid for their work, and are not entitled to some magic exclusivity for manufaturing it, on top of that money, since they did not work on top of that alread paid researh work either.
Yes. The US performs 42% of the world's drug research. If we put price controls in, all of the governments around the world would have to raise prices or remove drugs from their benefits plan. While the article below ignores the claim of "free riding" by other government, it later proves that without using that particular phrase.
http://thehill.com/opinion/healthcare/369727-us-drug-prices-higher-than-in-the-rest-of-the-world-heres-why
In the US - the gvmnt cannot negotiate the price of drugs - even for medicare/medicaid. Given that these programs are one of the biggest purchasers of drugs in the USA - this is a golden teat that pharmaceutical companies will continue to exploit - by raising prices all around. Why not, their biggest customer is guaranteed to pay any price.
Silence is a state of mime.